9DT-16010-54946
4 vaccinations
5 coded responses
41 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 229 / VA
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Moderna
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-19
- 2021-01-26
-
2021-02-02
Dose 2 — Moderna
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-04
- 2021-03-09
- 2021-03-16
- 2021-05-04
-
2021-08-03
Survey response — 6 months, dose 2MedDRA: Cough, Dyspnoea, Fatigue, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had a very bad cold with fatigue, SOB, cough, runny nose x 2 weeks after traveling to see family in Wisconsin. Negative COVID test. Now resolved.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-03
Dose 3 — Moderna
- 2022-02-02
-
2022-05-04
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Had a very mild cold (sore throat, runny nose, cough) but negative home COVID test.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Dose 4 — Pfizer-BioNTech
- 2022-09-20
-
2022-09-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-22
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Be unable to do your normal daily activitiesFree text: Swollen lymph node under armpit on the side of the injection, very painfulMedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Ongoing swollen lymph node under armpit on side of injection, but improved from yesterdayMedDRA releases: 2024-11 · check-in free text available
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-29
- 2022-10-04
-
2022-10-11
Survey response — day 21, dose 4MedDRA: Headache, Nasopharyngitis, Oropharyngeal pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold-like symptoms - runny nose, sore throat, headache, and fever. Tested negative for COVID on home test.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-12-20
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-02 | Moderna | |
| 3 | 2021-11-03 | Moderna | No |
| 4 | 2022-09-20 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: Had a very bad cold with fatigue, SOB, cough, runny nose x 2 weeks after traveling to see family in Wisconsin. Negative COVID test. Now resolved.
Release 11 — 6 months, dose 3
Symptoms: Had a very mild cold (sore throat, runny nose, cough) but negative home COVID test.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Swollen lymph node under armpit on the side of the injection, very painful
Systemic reaction (other): Ongoing swollen lymph node under armpit on side of injection, but improved from yesterday
Release 12 — day 21, dose 4
Symptoms: Cold-like symptoms - runny nose, sore throat, headache, and fever. Tested negative for COVID on home test.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release